Belgian company Syndesi Therapeutics was backed by Irish VC Fountain Healthcare on spin-out
Neuromod welcomes independent real-world study confirming clinical trial data
Company completes dosing in first round of trial of treatment for coeliac disease
Funding will drive commercialisation of Reactiv8 in critical US market
Galway-based Neurent looks to capitalise on treatment for one of the most common chronic conditions
Galway medical device group sees $2bn market for novel rhinitis device
Group eyeing up to 10 investments, mostly in therapeutics and medical device sectors
Large-scale trial shows improvement after 12 weeks, sustained results after 12 months
Cantillon: Venture capital business sells Inflazome to Roche for €380m
Company developing medicines for chronic inflammatory diseases such as Alzheimer’s
Acquisition of KaNDy Therapeutics a win for Irish VC investor Fountain Healthcare
Fountain Healthcare invests in French start-up Inotrem which targets condition with 35% mortality rate
Bank debt isn’t the only game in town for businesses. Here are some alternatives
Company plans to ramp up commercialisation of tinnitus treatment
YOU MAY ALSO LIKE...
Rugby World Cup: match analysis, interviews, fixtures and results
Inquests into the nightclub fire that led to the deaths of 48 people
Weddings, Births, Deaths and other family notices